Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
Product CodeMTG
Device Class 3

Premarket Approvals (PMA)
2019 2020 2021 2022 2023 2024
9 13 7 4 9 0

MDR Year MDR Reports MDR Events
2019 13 13
2020 6 6
2021 9 9
2022 4 4
2023 5 5
2024 3 3

Device Problems MDRs with this Device Problem Events in those MDRs
High Test Results 15 15
Incorrect Measurement 9 9
Low Test Results 8 8
Non Reproducible Results 5 5
Incorrect, Inadequate or Imprecise Result or Readings 4 4
Adverse Event Without Identified Device or Use Problem 4 4
No Apparent Adverse Event 1 1
Insufficient Information 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 19 19
No Consequences Or Impact To Patient 14 14
No Known Impact Or Consequence To Patient 7 7

-
-